AI
LMNL

Atom Investors’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Atom Investors’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,512
Closed -$64K – 454
2020
Q4 		$64K Sell
1,512
-3,791
-71% -$207K 0.01% 355
2020
Q3 		$590K Buy
5,303
+2,848
+116% +$385K 0.06% 243
2020
Q2 		$265K Buy
+2,455
New +$217K 0.02% 334

Other funds holding LMNL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Atom Investors's LMNL Position: Q1 2021 in Review

Atom Investors sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2021, closing a stake of 1,512 shares — an estimated $64K sold.

Atom Investors first reported a position in LMNL in Q2 2020 and held it in 3 quarters. The position peaked at $590K in Q3 2020. 11 funds tracked by Wall St. Rank hold LMNL as of Q1 2021.

  • Atom Investors reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2021 after selling out during the quarter.
  • Atom Investors sold 1,512 Liminal BioSciences Inc. Common Shares shares in Q1 2021, an estimated $64K.
  • Atom Investors first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2020 and held it in 3 quarters.
  • Atom Investors's Liminal BioSciences Inc. Common Shares position peaked at $590K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.